FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters. And Stemirna said in July it had halted work at a planned vaccine factory in Shanghai, citing lack of demand. Their setbacks come just as Moderna, which developed one of the world's first mRNA vaccines against COVID, is setting up manufacturing in Shanghai, with plans to launch up to 15 new mRNA medicines in the next five years and bring up to 50 candidates into clinical trials. "At the moment China's mRNA is still just taking off," a spokesperson for CSPC said,referring questions on mRNA plans to a social media post highlighting a re
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing the COVID-19 vaccine [Business Insider]Business Insider
- Metagenomi, Moderna terminate gene editing collaboration [Seeking Alpha]Seeking Alpha
- What to Watch in the Day Ahead - Thursday, May 2 [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks: Buy, Sell, or Hold? [Yahoo! Finance]Yahoo! Finance
- We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation Package [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 5/1/24 - Form 144
- 4/26/24 - Form 4
- 4/24/24 - Form 144
- MRNA's page on the SEC website